Statistical
analysis is often used in medical studies to provide evidence for an association between a treatment and a patient condition.
The work in this paper is motivated by a recent medical study which analyzes the temporal association between a treatment (i.e., an implant procedure) and the rare autoimmune disorders, polymyositis and dermatomyositis (PM/DM),
To address this association mathematically, this paper develops a probability model based on the multinominal distribution that can be used to make statistical inferences about the timing of incidence of a treatment/condition pair. This paper details an empirical study of this model using Monte Carlo simulation. It also describes some analytical results developed in subsequent research efforts, Data from the medical study illustrate the application of this model and its results.
INTRODUCTION
Medical studies often provide statistical data as evidence for an association between a treatment (e.g., medical procedure, drug, therapy) and a subsequent patient condition (e.g., disorder, syndrome, disease).
Frequently reported statistics such as the number or proportion of a treatment condition pair are inherently static and fail to capture an additional dimension often found in patient data: the timing of the incidence of a patient condition after the treatment has been administered.
The latter is referred to as temporal association (Cukier et al. 1993) . Approaches designed to detect temporal association are potentially more powerful than static approaches in establishing connections between treatments and patient conditions.
Whereas a static approach might consider the number of incidence in a given population of patients statistically insignitlcant, a temporal approach applied to the same data might find the timing of the Austin, Texas 78712-1175
End to End "Simulation Department Schlumberger Austin Research Center Austin, Texas 78720 incidence to be extremely rare. For example, while the total number of patients who develop a particular condition any time after receiving the treatment may be very close to the expected number, these patients may do so much sooner than expected. This paper develops a mathematical model to study temporal association in a problem encountered in a medical study conducted by Cukier et al. (1993) .
Their study is designed to determine the existence of an association between the uncommon autoimmune disorders PM/DM and an implant procedure used to correct wrinkles due to aging, acne scars, and other superficial skin defects. Cukier et al. (1993) assess the likelihood of the incidence timings for the 9 patients who developed the disorders against the temporal probability distribution using Monte Carlo simulation.
The objective of this paper is to formulate a mathematical model to describe the problem studied in Cukier et al. (1993) , and to present the results of a Monte Carlo study used to support the results in Cukier et al. (1993) . The paper also describes some analytical results that extend the Monte Carlo simulation study. The remainder of the paper is organized as follows. In Section 2, the mathematical model is formulated.
The model is not restricted to the particular problem studied in Cukier et al. (1993) . In fact, it is general enough to study the temporal amociation between any patient condition and treatment. Section 3 describes the details of the Monte Carlo simulation model and the results used in Cukier et al. (1993) . Section 4 describes some of the analytical results that extend this research, Section 5, summarizes the results and provides some concluding remarks.
MODEL FORMULATION
The problem described in Section 1 can be restated to facilitate the construction of the underlying probability y model.
Suppose the units in the sample are balls (rather than patients who develop the disorder) and the monthly cells on the time scale are urns. An equivalent problem formulation is that of randomly distributing N balls into Q urns where the balls act independently.
The probability of any ball falling into theqthur nisu~, q=l, other measures could be used to characterize temporal association, R is a natural quantity to consider for the medical study because it measures the mean latency period for a particular sample of patients. In other words, it can be interpreted as the cumulative number of patient-months until all patients in which the disorder occurred actually developed the disorder after receiving the implant treatment.
For example, from the data in Table 1 , the observed value of R is 61. In other words, it took a total 61 patient-months for all 9 patients to develop an autoimmune disorder after the implant treatment. Therefore, R is a way to compare different patient group configurations on the basis of temporal ordering.
In order to study the temporal association, one must characterize the probability distribution of R and then assess the likelihood of observed values of R being generated from this distribution, For example, Cukier et al. (1993) assess the likelihood of the disorders occurring in the 9 patients aa soon after treatment as they did. Stated in terms of R, they sssess the likelihood of a randomly selected 9 patient group (from the multinominal distribution with probabilities given in Figure 1 ) having a total patient-month value of less than or equal to 61, which is just the tail probability P{R < 61}.
A small value for this tail probability provides evidence for a strong temporal association between the disorders and the implant treatment since this indicates that disorders occur much sooner than expected from the patient population. . ,
Expression (5) illustrates that the tail probability i P{R < 61} is bounded above by 0.104, This means close to 90% of all possible 9 patient groups would have a patient-month total of greater than or equal to 62. While this indicates that the observed R for the 9 patient group in Table 1 is somewhat rare, it is far from definitive since statistical significance in most studies is declared on a probability of 0.05 or less. In most instances, the Chebyshev inequality is quite conservative and does not provide a tight upper bound. In fact, this will be demonstrated in Section 4 to be the case, 1,000,000 (6) The data illustrates that the probability of observing R~61 is extremely low. Out of the 1,000,000 replications, 92 fall at or below the value of61. Therefore, a point estimate for P{R~61} is P = 9.2 x 10-5.
Since the sample size is large and (6) is a proportion, large sample theory can be used to produce an approximate confidence interval for P{R < 61}. Using the procedure found in Bickel and Doksum (1977) , page 160, an approximate (1 -a) x 100%, (O < a < 1) confidence interval for P{R < 61) is where S is the number of Monte Carlo simulation replicates observed in the tail, k. is the 1 -$ percentile from the normal distribution, and q represents the total number of simulation replicates. Ln this example, S = 92, k~= 1.96 (for a 95% confidence level), and q = 1,000,000. Hence, the observed confidence interval is (7.5024x 10-s, 1.1282x 10-'4). Bickel and Doksum (1977) state that the use of this confidence interval is satisfactory as long as the smaller of (1, 000, 000)(P{R~61)) or (1, 000, 000)(1 -P{R6 1}) is at least 5. For the example in this paper, the value is estimated to be 92.
ANALYTICAL APPROACHES
The probability distribution for R can be determined analytically by addressing the following combinatorial problem:
find all possible values of {Ng, q = 1,..., Q} such that Once the possible combinations of {Nq } are known, the probability that R equals some prespecified value can be calculated analytically using the prcjbabilities from the multinominal distribution. Since we are interested in a cumulative tail probability, this :procedure would have to be repeated for each fixed Vialue of R.
Total enumeration for all the {Nq, q = 1, . . . . Q) that satisfy the above two constraints for different values of R is quite difficult because the number c~fpossible combinations of the {Ng } grows exponentially in the size of Q, N, and R (see Jacobson and Morrice 1996) . Hence a total enumeration approach is impractical for realistic sized problems such as the one considered in Cukier et al. (1993) .
Fortunately, this problem can be solved without using total enumeration.
In order to define this procedure, some additional notation is needed. Let n~ be the total number of balls in the first q urns, q = 1,2 ,..., Q. By definition, nq =~~=1 Ni. In addition, let
Rq = x iNi i=l and Pq,n,r = P{Rq = r, n~= n} for q = 1,2,..., Q, n = 1,2,,.., N, r =~,n+ 1,. ... qn. Finally, let Vq,~,, be the total number of patient samples (or vectors) of size n that are possible for the first q urns with Rq = r and nq = n balls,
The problem is to determine the distribution for RQ(= R), i.e., pQ,~,,.
The following theorem provides the basis for a recursive approach to calculating Pq,n,r.
Theorem
1 The probability p~,n,r can be computed using the recursion h(q,n,r) Pq,n,r = x () Pq-l,n-m,.-qm~~~( 9) mzO forq=2,3,..,, Q,n=l,2,..., N, andr=n, n+ 1,.. .,qn, where h(q, n,r) = min{n, rr/ql }. The ini- 
Proof:
See Jacobson and Morrice (1996) .
The recursion in (9) can be successively applied, starting with the values q = 2 and n = 1, until the desired values for q(= Q), n(= N), and r are reached. A recursive algorithm is described in Jacobson and Morrice (1996) .
A corollary to Theorem 1 can be used to determine the number of vectors for each possible value of R. corollary 1 The number of vectors, Vq,n,r, can be computed using the recursion h(q,n,r) v q,n,r = x () Vq-l,n-m,r-qm~( lo) mzO forq=2,3,,.., Q, n=l,2,..., N, andr=n, n+ 1,..., qn, where h(q, n, r) = min{n, rr/ql}.
The ini. tial boundary conditions for this recursion are See Jacobson and Morrice (1996) .
To solve the recursion in (9) for all values of r (r=l,2,..., QN), in the worst case, QN recursions must be constructed for each value of r, where each recursion has at most N + 1 parts in the summation, Therefore, the computational effort needed to determine the entire distribution for R is polynomial in Q and N, where the largest polynomial term is of order Q2N3.solvingthe recursion in (10) The probability distribution is given in Figure 3 . For R~61, the P{R~61} = 1.0250x 10-4. This value validates the Monte Carlo simulation results reported by Cukier et al. (1993) and described in the last section, since the confidence interval produced by the simulation covers 1.0250 X 10-4.
Convolving the distribution in Figure 1 with itself N times provides an alternative way to formulate the probability distribution of R. This follows since R is also the sum of sample of size N from the distribution in Figure 1 . The following theorem provides a recursive procedure for calculating the probability distribution of R using this convolution formulation.
Theorem 2 The probability pq,.,r can be computed using the convolution formula r-l Pq,n+l,r = x Pq,n,i%-i i=mac (l,r-q) forq=l,2,..., Q,n=l,2, N.., N-l, r=n+l, n+ 2 ,. ... q(n + 1). The initial boundary conditions for this formula are Proofi See Jacobson and Morrice (1996) .
When the convolution formula in Theorem 2 is set up as a recursive aIgorithm, this algorithm requires polynomial computational effort in Q and N to generate the entire distribution for R. To obtain this distribution for Q alone, the largest polynomial term is of order Q2N2.
However, if this distribution is required for all q = 1,2 ..,, Q, then the largest polynomial term is of order Q3N2.
The convolution formulation has the advantage over the formulation in Theorem 1 in computational speed if the distribution for R is required for the single value Q. However, if the distribution of R is required for all values of g = 1,2,,., Q, then the Theorem 1 formulation has the advantage over the convolution formulation in computational speed. This follows from the order of the largest polynomial terms for the two approaches.
Theorems
1 and 2 eliminate the need to perform a Monte Carlo simulation to calculate the probability distribution for R. In addition to being able to produce exact results, the algorithms associated with Theorems 1 and 2 are very fast relative to the simulation described in the last section. In particular, the simulation takes about 21.6 CPU seconds on the DEC AlphaServer 2100 4/275 to produce the data for The solution algorithms using these formulations are very efficient and can be used to solve realistically sized problems.
The model formulation presented in this paper is general and not restricted to the specific problem given in the cited medical study. Studies~similar to Cukier et al. (1993) are common in the medical literature. Hochberg (1993) cites several examples and specifically discusses Cukier et al. (1993) and Bridges et al. (1993) as similar types of studies. The latter focuses on a possible connection between silicon bresst implants and rheumatic disease.
